| (210) | Number of the EPO application | 16744237 |
| (220) | Filing date of the EPO application | 2016.01.29 |
| (80) | EPO patent specification publication (B) | EPB nr. 40/2020, 2020.09.30 |
| (110) | EPO patent number | 3250208 |
| (11) | Number of the document | MD 3250208 T2 |
| (21) | Number of the application | e 2017 0317 |
| (71) | Name(s) of applicant(s), code of the country | ONCOCEUTICS INC., US; |
| (72) | Name(s) of inventor(s), code of the country | STOGNIEW Martin, US;
ALLEN Joshua E., US;
POTTORF Richard S., US;
NALLAGANCHU Bhaskara Rao, US;
OLSON Gary L., US;
SUN Yanjun, US; |
| (73) | Name(s) of owner(s), code of the country | ONCOCEUTICS INC., US; |
| (54) | Title of the invention | 7-benzyl-4-(4-(trifluoromethyl)benzyl)-1,2,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(4h)-one and salts thereof and their use in therapy |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 31/519 (2006.01.01); C07D 471/12 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.02.28 |
| (49) | Date of publication of the translation of the validated European patent specification | 2021.02.28 |
| (30) | Priority | 201562109737 P, 2015.01.30, US; 201562148844 P, 2015.04.17, US; 201562233757 P, 2015.09.28, US |
| (74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2016/015817, 2016.01.29 |
| (87) | International publication | WO 2016/123571, 2016.08.04 |